ASCP 2019 Recorded Sessions

Laboratory Professional Track

Twelve sessions developed by laboratory professionals, for laboratory professionals

Each 90-minute recorded session offers 1.5 CMLE credits

Access the full session audio and synced presentation video, plus the downloadable course materials

Topic areas covered include hematology/coagultion, transfusion medicine/blood banking, microbiology, and clinical chemistry

2019 Recorded Session Package

12 Session Package

ASCP Members: $129

List Price: $149

Order Now

Individual Sessions

ASCP Members: $20

List Price: $25

Learn More

Full Session Listing

All Sessions Hematology/Coagulation Transfusion Medicine/Blood Banking Microbiology Clinical Chemistry

Advances in the Diagnosis of Urinary-Tract Infections and Implications for Antimicrobial Stewardship

This session reviews the technologic advances in detection of UTIs and discuss related clinical studies and potential impacts on antibiotic stewardship, including data from the speakers.

Order Now

Body-Fluid Analysis: Case Studies from the Bench

Participants learn a systematic approach to distinguishing the morphologic differences in benign, reactive, and malignant body-fluid cells. Case-history presentations illustrate changes in cell populations, with examples of various benign, reactive, and malignant conditions.

Order Now

Cellular Therapy: Past, Present, and The Future

This lecture provides an introduction to cellular therapy from its early days to present time, and the future. Cellular therapy has been utilized as an effective clinical tool in treating blood and marrow disorders for decades. With advancement in science and technology, different type of cells can be used to treat a variety of conditions and diseases and the possibilities are endless.

Order Now

Emerging Issues in the Coagulation Laboratory

This session looks at emerging issues and complications in the coagulation laboratory. It includes information that has been obtained from proficiency testing and field studies. Case studies are utilized to demonstrate some of the challenges that coagulation laboratories face regarding patient results in the presence of these treatments, as well as the impact of their coagulation reagents.

Order Now

Gram Stains: Improving the Original Multiplex Microbiology Test

This session presents five keys to improve Gram stains and presents practical approaches to comply with College of American Pathologists (CAP) regulations for microscopy. The five keys include the selection of a proper specimen, the application of the specimen to the slide, optimized staining technique, interpretation in the context of body site, and concise and understandable reporting. Lastly, the reporting of positive blood-culture Gram stain results in the context of real-time molecular tests is addressed.

Order Now

Implementation of MALDI-TOF MS in Clinical Microbiology

Matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF MS) is a revolutionary technology in clinical microbiology for the rapid identification of culture isolates. This technology is less labor-intensive than current identification methods and provides accurate results in minutes from a single isolated colony. This presentation presents the principles of MALDI-TOF MS, the steps involved in setting up a MALDI identification, and the use of this technology in clinical microbiology.

Order Now

Internal Audit Process: Driving Continual Process Improvement in the Blood Bank

This session describes the formal internal assessment program for the clinical laboratory including determining what to monitor, the assessment process, and effectiveness checks post assessment. Examples of actual assessments conducted by the transfusion service provide examples of internal audits that have driven process improvements.

Order Now

Is Therapeutic Drug Monitoring Irrelevant in the Era of Personalized Medicine?

Therapeutic drug monitoring (TDM) and pharmacogenomics testing are clinical laboratory-based methods for supporting pharmacotherapy. In this session, a practical approach in which pharmacogenomics tests are useful (therapy with warfarin, tamoxifen, etc) for specific drugs and in which TDM is satisfactory are discussed, with emphasis on free (unbound) drug monitoring and unique application of therapeutic drug monitoring in identifying clinically important drug-herb interactions.

Order Now

Tube or Gel: Resolving ABO/Rh Discrepancies with Confidence

This session emphasizes a systematic approach to the determination of the possible causes of ABO or Rh testing discrepancies in tube and gel methodologies. Interactive case studies are featured.

Order Now

The Who, What, Why, and How of Testing Algorithms: Making an Impact One Test at a Time

This session describes steps made by an integrated health-care delivery system to develop testing algorithms that not only streamline workflow and improve test utilization but, most importantly, improve patient care. We will review the who, what, why, and how of developing test algorithms. We will also provide strategies and data specific to microbiology, hematology, and coagulation best practices.

Order Now

Why Negative Interferences in Immunoassays Cause More Diagnostic Errors than Positive Interferences: Methods for Error Detection and Correction

In this session, case reports are presented to demonstrate the dangers of negative and bidirectional interferences in clinical laboratory test results. Moreover, various approaches to identify such interferences are addressed, along with approaches for elimination of such interferences when possible. Tips to effectively communicate with clinicians when they report potentially adverse or inaccurate laboratory test results are also provided.

Order Now

Would Your Flow Cytometry Assays Meet the Clinical Laboratory Standards Institute (CLSI) H62 Validation Guidelines?

In 2017, the Clinical Laboratory Standards Institute (CLSI) approved a proposal for a new guideline to address the validation of assays performed by flow cytometry. Practical instructions are given for pre-examination-phase activities: specimen requirements, reagent evaluation, instrument qualification and standardization, and assay optimization and validation. There is guidance for examination-phase activities such as instrument monitoring and quality-control procedures. Best practices for postexamination activities, such as data review, reporting, storage, and retention, are described. This presentation reviews the key elements of the CLSI proposal and provides real-life examples of how its elements could affect flow cytometry in the laboratory.

Order Now